A cost-utility analysis of losartan versus atenolol in the treatment of mild to moderate hypertension

被引：1

作者：

Anis, AH

Sun, H

Singh, S

Woolcott, JC

Nosyk, B

机构：

[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada

[2] Canadian HIV Trials Network, Vancouver, BC, Canada

[3] BC Ctr Dis Control, Vancouver, BC, Canada

来源：

VALUE IN HEALTH | 2004年 / 7卷 / 03期

关键词：

D O I：

10.1016/S1098-3015(10)62383-2

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：323 / 323

页数：1

共 50 条

[1] A cost-utility analysis of losartan versus atenolol in the treatment of hypertension with left ventricular hypertrophy
Anis, AH
Sun, HY
Singh, S
Woolcott, J
Nosyk, B
Brisson, M
PHARMACOECONOMICS, 2006, 24 (04) : 387 - 400
[2] A Cost-Utility Analysis of Losartan versus Atenolol in the Treatment of Hypertension with Left Ventricular Hypertrophy
Aslam H. Anis
Huiying Sun
Sonia Singh
John Woolcott
Bohdan Nosyk
Marc Brisson
PharmacoEconomics, 2006, 24 : 387 - 400
[3] Economic evaluation of telmisartan, valsartan and losartan in combination with hydrochlorothiazide for treatment of mild-to-moderate hypertension in Greece: a cost-utility analysis
Kourlaba, Georgia
Fragoulakis, Vassilios
Theodoratou, Dorina
Maniadakis, Nikos
JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2013, 4 (02) : 81 - 88
[4] QUINAPRIL VERSUS ATENOLOL IN THE TREATMENT OF MILD TO MODERATE ESSENTIAL-HYPERTENSION
BAHENA, JH
ESTRELLA, ME
MUNOZ, M
CLINICAL THERAPEUTICS, 1992, 14 (04) : 527 - 536
[5] COST-UTILITY ANALYSIS OF CHOLINESTERASE INHIBITORS IN THE TREATMENT OF MILD TO MODERATE ALZHEIMER'S DISEASE
Turongkaravee, S.
VALUE IN HEALTH, 2010, 13 (07) : A502 - A502
[6] The cost-utility of aliskiren in the treatment of mild to moderate hypertension. A Canadian health care system perspective
Lee, A.
Barry, S. J.
Leiter, L.
Nanji, A.
Annemans, L.
Tucker, D.
Michaliszyn, A. F.
Barbeau, M.
Vincze, G.
VALUE IN HEALTH, 2008, 11 (03) : A202 - A203
[7] Cost-utility analysis of timolol versus latanoprost versus travoprost in the treatment of glaucoma and ocular hypertension
Lilliu, H
Le Pen, C
Berdeaux, G
VALUE IN HEALTH, 2002, 5 (06) : 552 - 553
[8] Cost-utility analysis of eprosartan compared to enalapril and ramipril in the treatment of moderate to severe hypertension in Sweden
Lindgren, P.
Schwander, B.
Zollner, Y.
Jonsson, B.
VALUE IN HEALTH, 2006, 9 (06) : A353 - A353
[9] A COMPARISON OF BISOPROLOL AND ATENOLOL IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION
LEWIS, R
MACLEAN, D
IOANNIDES, C
JOHNSTON, A
MCDEVITT, DG
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 26 (01) : 53 - 59
[10] LISINOPRIL VERSUS ATENOLOL IN THE TREATMENT OF PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION
LAPLANTE, LE
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1994, 55 (09): : 1027 - 1037

← 1 2 3 4 5 →